Finance

Lists
Why is EVH up 8,24%?
Dive Deeper
EVH:NYSE
Evolent Health Inc
4,60 $
+8,24%
(+0,35) 1D
4,54 $
-1,30% (-0,060)
After hours
Closed: 13 հոկ, 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVH...
Open
4,30 $
High
4,71 $
Low
4,16 $
Mkt. cap
520,07 մլն
Avg. vol.
2,24 մլն
Volume
2,56 մլն
52-wk high
8,30 $
52-wk low
2,10 $
EPS
-4,57 $
Beta
1,02
Shares outstanding
113,06 մլն
No. of employees
4 հզր
Open
4,30 $
High
4,71 $
Low
4,16 $
Mkt. cap
520,07 մլն
Avg. vol.
2,24 մլն
Volume
2,56 մլն
52-wk high
8,30 $
52-wk low
2,10 $
EPS
-4,57 $
Beta
1,02
Shares outstanding
113,06 մլն
No. of employees
4 հզր
News stories
From web sources and news partners
About Evolent Health Inc
CEO-
Employees4,2 հզր
Founded2011
Headquarters-
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to EVH in the past 3 months
Strong buy
Buy
9
Hold
3
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for EVH in the last 3 months.
Highest
Current 4,60 $
8,00 $ (+73,91%)
Average
5,80 $ (+26,09%)
Lowest
3,00 $ (-34,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Hold
Maintained
3,00 $
-34,8%
10/06/2026
John Stansel
J.P. Morgan
Buy
Reiterated
6,00 $
+30,4%
08/18/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
6,00 $
+30,4%
08/17/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
6,00 $
+30,4%
08/12/2026
Daniel Grosslight
Citi
Buy
Upgraded
6,00 $
+30,4%
08/11/2026
Richard Close
Canaccord Genuity
Buy
Maintained
6,00 $
+30,4%
08/10/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/10/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
6,00 $
+30,4%
08/07/2026
Sean Dodge
BMO Capital
Buy
Maintained
6,00 $
+30,4%
08/06/2026
Matthew Shea
Needham
Buy
Reiterated
5,00 $
+8,7%
08/06/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/06/2026
David Larsen
BTIG
Buy
Reiterated
8,00 $
+73,9%
07/16/2026
Kevin Caliendo
UBS
Buy
Reiterated
5,00 $
+8,7%
05/08/2026
Jeffrey Garro
Stephens
Buy
Maintained
7,00 $
+52,2%
02/25/2026
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
0,02 $ / -0,02 $
+229,87%beat
Revenue / Est. (USD)
652,52 մլն / 599,79 մլն
+8,79%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
479,53 մլն
468,72 մլն
496,25 մլն
652,52 մլն
Cost of goods sold
379,76 մլն
371,47 մլն
412,47 մլն
571,68 մլն
Cost of revenue
379,76 մլն
371,47 մլն
412,47 մլն
571,68 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,50 մլն
61,86 մլն
72,36 մլն
67,99 մլն
Operating expense
99,12 մլն
106,89 մլն
93,91 մլն
89,55 մլն
Total operating expenses
478,88 մլն
478,36 մլն
506,38 մլն
661,24 մլն
Operating income
658,00 հզր
-9,64 մլն
-10,14 մլն
-8,72 մլն
Other non operating income
80,00 հզր
-552,00 հզր
742,00 հզր
109,00 հզր
EBT including unusual items
-19,96 մլն
-430,81 մլն
-25,72 մլն
-25,65 մլն
EBT excluding unusual items
-14,62 մլն
-28,30 մլն
-25,26 մլն
-24,80 մլն
Income tax expense
906,00 հզր
-1,68 մլն
910,00 հզր
2,72 մլն
Effective tax rate
-4,54%
0,39%
-3,54%
-10,59%
Other operating expenses
-
-
-
-
Net income
-20,86 մլն
-429,13 մլն
-26,63 մլն
-28,36 մլն
Net profit margin
-4,35%
-91,55%
-5,37%
-4,35%
Earnings per share
0,05
-
-0,02
0,02
Interest and investment income
964,00 հզր
868,00 հզր
1,01 մլն
703,00 հզր
Interest expense
-16,48 մլն
-19,01 մլն
-16,87 մլն
-16,86 մլն
Net interest expenses
-15,51 մլն
-18,14 մլն
-15,85 մլն
-16,16 մլն
Depreciation and amortization charges
23,62 մլն
45,04 մլն
21,56 մլն
21,57 մլն
EBITDA
18,67 մլն
29,70 մլն
5,62 մլն
7,05 մլն
Gain or loss from assets sale
-
-14,87 մլն
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps